Table 3.
BP term or cluster | Description | N | X 2 adj A | Orthologues B |
---|---|---|---|---|
GO:0007155 |
Cell adhesion (BP)C |
6 |
<0.0001 |
FBgn0034660, FBgn0000547, FBgn0031879, FBgn0000464, FBgn0000117, FBgn0026562 |
GO:0007155, GO:0008360 |
Cell adhesion (BP)C, regulation of cell shape (BP)C |
3 |
<0.0001 |
FBgn0000547, FBgn0000464, FBgn0000117 |
GO:0007391 |
Dorsal closure (BP)C |
3 |
0.0037 |
FBgn0000299, FBgn0000547, FBgn0000117 |
GO:0046331 |
Lateral inhibition (BP)C |
4 |
0.0059 |
FBgn0010473, FBgn0000547, FBgn0243514, FBgn0053196 |
IPR002172 |
Low-density lipoprotein (LDL) receptor class A repeat |
3 |
<0.0001 |
FBgn0031879, FBgn0053196, FBgn0261341 |
IPR013032 |
EGF-like region, conserved site |
5 |
<0.0001 |
FBgn0003137, FBgn0026403, FBgn0031879, FBgn0243514, FBgn0053196 |
GO:0005509 |
Calcium ion binding (MF) |
7 |
<0.0001 |
FBgn0026403, FBgn0031879, FBgn0000079, FBgn0031464, FBgn0037963, FBgn0053196, FBgn0026562 |
IPR003599, IPR007110 |
Immunoglobulin subtype, Immunoglobulin-like 6 |
6 |
<0.0001 |
FBgn0003137, FBgn0010473, FBgn0000547, FBgn0005666, FBgn0000464, FBgn0004369 |
IPR003599, IPR007110, IPR003961, IPR008957 |
Immunoglobulin subtype, Immunoglobulin-like, Fibronectin, type III, Fibronectin type III domain |
5 |
<0.0001 |
FBgn0010473, FBgn0000547, FBgn0005666, FBgn0000464, FBgn0004369 |
IPR001660, IPR010993, IPR011510, IPR021129 |
Sterile alpha motif domain, Sterile alpha motif homology, Sterile alpha motif, type 2, Sterile alpha motif, type 1 |
3 |
<0.0001 |
FBgn0000182, FBgn0031762, FBgn0039075 |
IPR018247 |
EF-Hand 1, calcium-binding site |
3 |
0.0019 |
FBgn0031464, FBgn0013809, FBgn0026562 |
GO:0004867 |
Serine-type endopeptidase inhibitor activity (MF) |
3 |
<0.0001 |
FBgn0003137, FBgn0026721, FBgn0053196 |
GO:0006030, GO:0008061, IPR002557 |
Chitin metabolic process (BP)C, chitin binding (MF), Chitin binding domain |
3 |
<0.0001 |
FBgn0027600, FBgn0051973, FBgn0261341 |
IPR017853 |
Glycoside hydrolase, superfamily |
3 |
<0.0001 |
FBgn0053080, FBgn0000079, FBgn0026415 |
GO:0030036 |
Actin cytoskeleton organizationD |
2 |
0.0080 |
FBgn0000182, FBgn0085447 |
GO:0006470 |
Protein dephosphorylationD |
2 |
0.0242 |
FBgn0000464, FBgn0004369 |
GO:0007498 |
Mesoderm developmentD |
2 |
0.0130 |
FBgn0005666, FBgn0026562 |
GO:0008045 |
Motor axon guidanceD |
2 |
0.0013 |
FBgn0000464, FBgn0004369 |
GO:0005975 |
Carbohydrate metabolic processD |
2 |
0.0008 |
FBgn0053080, FBgn0000079 |
GO:0007414 |
Axonal defasciculationD |
2 |
<0.0001 |
FBgn0010473, FBgn0004369 |
GO:0007156 |
Homophilic cell adhesionD |
2 |
0.0001 |
FBgn0000547, FBgn0037963 |
GO:0006979 |
Response to oxidative stressD |
2 |
0.0033 |
FBgn0031464, FBgn0036756 |
GO:0016337 | Cell-cell adhesionD | 2 | <0.0001 | FBgn0000547, FBgn0000117 |
AX2adj refers to the significance of the Fisher’s exact test with a Benjamini-Hochberg correction for multiple comparisons.
BOrthologues correspond to those pictured in Figure 2B (left panel) and represent Drosophila melanogaster genes that are listed in FlyBase.
CTerms that were significant BP terms and were part of a significant gene annotation cluster.
DTerms that represented significant BP terms but did not form a significant gene annotation cluster.